Search
Showing results for "1"
Research
Real-world glycaemic outcomes in children and young people on advanced hybrid closed-loop therapy: A population-based study in Western AustraliaTo evaluate real-world glycaemic outcomes in children with type 1 diabetes commencing advanced hybrid closed loop therapy and to explore these outcomes based on the cohort's clinical and socioeconomic characteristics.
Research
Using participatory action research to prevent suicide in Aboriginal and Torres Strait Islander communitiesUsing a participatory action research approach, the communities were supported to identify the risk factors challenging individuals, families and communities...
Research
Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013We generated updated estimates of child mortality in various age groups for 188 countries from 1970 to 2013.
Research
Otitis media at 6-monthly assessments of Australian First Nations children between ages 12–36 months: Findings from two randomised controlled trials of combined pneumococcal conjugate vaccinesIn remote communities of northern Australia, First Nations children with hearing loss are disproportionately at risk of poor school readiness and performance compared to their peers with no hearing loss. The aim of this trial is to prevent early childhood persisting otitis media (OM), associated hearing loss and developmental delay.
We interviewed 17 parents with a daughter with Rett syndrome to gain their perspectives on how their daughter communicates and barriers.
News & Events
Top Up PhD ScholarshipsApplications are open for the next round of our Top Up Scholarships for students who are undertaking their research in type 1 diabetes-related fields.
News & Events
Seed Funding GrantsApplications are open for the next round of our Seed Funding Grants for researchers dedicated to type 1 diabetes
News & Events
International Clinical Trials DayTo celebrate International Clinical Trials Day, we are highlighting a couple of a current trials underway at the Children's Diabetes Centre at the Kids Research Institute Australia and Perth Children's Hospital
Research
Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancersWe demonstrated the efficacy of FPPa-OmoMYC in inhibiting breast cancer growth when injected orthotopically in TNBC allografts